Skip to main content

Day: May 19, 2025

MacKenzie Realty Capital Reports Third Quarter FY 2025 Financial Results and Suspends Quarterly Common Dividend

ORINDA, Calif., May 19, 2025 (GLOBE NEWSWIRE) — MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) today announced its financial results for the third quarter ended March 31, 2025 and announced that its Board Of Directors is suspending the company’s cash dividend payable to common stockholders. Key Financial Highlights:Operating Results for the Three Months Ended March 31, 2025:Net revenues for three months ended March 31, 2025, were $4.3 million, an increase of 5% from $4.1 million in the same period of 2024. Net operating loss was $5.8 million, as compared to a net operating loss of $2.7 million in the same period of 2024. Net loss was $6.1 million, compared to a $2.9 million loss in the same period of 2024. The Company had negative $3.1 million of funds from operations (“FFO”) for the quarter. The...

Continue reading

REalloys Inc., Signs Joint MOU with Saskatchewan Research Council Enabling Processing of Rare Earth Materials for High Performance Magnet Production in Q2 2025

DALLAS, May 19, 2025 (GLOBE NEWSWIRE) — Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), announces that its merger target REalloys Inc. (“REA” or “REalloys”), has signed a joint Memorandum of Understanding (“MOU”) with the Saskatchewan Research Council (“SRC”) to begin working together to advance REA’s initiative of commercial production of high-performance rare earth magnet materials. REA’s planned production starts in Q2, with targeted expansion to 500 metric tonnes (“mt”) per year of magnet materials in 2026, and 1,000 mt by 2028.   This is a major milestone to achieve the objective of a secure & resilient North American magnet materials & magnets supply chain focused on demand from U.S. Protected Markets (includes: National Defense Stockpiles (“NDS”), Defense Industrial Base (“DIB”), Nuclear Industrial...

Continue reading

Lifeward Names Mark Grant as New CEO

Industry veteran brings 30 years of commercial leadership experience MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has been appointed as the Company’s new President and Chief Executive Officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CEO, will serve as Co-CEO and, as previously announced, will serve in an advisory capacity until the end of June to assist with the transition, and thereafter on an as-needed basis through the end of 2025. “Mark brings 30 years of combined experience in commercial leadership, channel development and strategic solutions, and is the...

Continue reading

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a high-volume workforce drug test for Barcaldine Regional Council in remote Queensland, Australia, (the “Council”) using its Intelligent Fingerprinting Drug Screening System (the “System”). This initiative supports the Company’s expansion into regional and remote workforce testing markets. In less than 90 minutes, more than 160 employees, representing 100% of the workforce, were tested and cleared as fit for duty before the...

Continue reading

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

— First ever clinical data supporting safety and efficacy of Prime Editing in humans — — Initial data from first patient dosed in Phase 1/2 trial finds single dose of PM359 led to 58% DHR positivity by Day 15 and 66% by Day 30, well above levels believed to be potentially curative — — Rapid engraftment observed in both neutrophils and platelets — — Encouraging safety profile; no serious adverse events related to PM359 — — Initiating efforts to explore continued clinical development opportunities for PM359 external to Prime Medicine — CAMBRIDGE, Mass., May 19, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced positive initial data...

Continue reading

Skillful Craftsman Education Announces New Business Initiatives

Shenzhen, China, May 19, 2025 (GLOBE NEWSWIRE) — Skillful Craftsman Education Technology Limited (“Skillful Craftsman” or the “Company”) (NASDAQ: EDTK), a company focused on advancing technological innovation in education through the digital transformation of educational institutions, today announced new business initiatives designed to propel the Company’s growth. Mr. Bin Fu, Chief Executive Officer of Skillful Craftsman announced, “Our new business initiatives entail an innovative focus and a new set of business priorities. These include the empowerment of AI and digital technology in education, the building of an intelligent learning platform, and the provision of innovative education technology consulting services. We believe that we have developed a new strategy for the Company to move forward that...

Continue reading

New Century Logistics (BVI) Limited and Silk Way Airlines have reached a strategic cooperation to jointly explore a new pattern of international air logistics

Hong Kong, China, May 19, 2025 (GLOBE NEWSWIRE) — On May 16, 2025 —— Hong Kong leading logistics solutions provider New Century Logistics (BVI) Limited (hereinafter referred to as “New Century”) today announced the formal signing of a Memorandum of Understanding (“MOU”) with Silk Way Airlines Limited (hereinafter referred to as “Silkway”), a well-known air cargo airline in Hong Kong. Both parties will explore innovative solutions in the international air freight logistics sector based on resource sharing and complementary strengths, aiming to enhance global supply chain efficiency for their clients. Stronger collaboration According to the MOU, New Century and Silkway will conduct in-depth cooperation in the following directions:Joint development of international air freight logistics solutions: integrating...

Continue reading

Bath & Body Works Appoints Daniel Heaf as Chief Executive Officer

Heaf Brings Proven Track Record of Driving Growth Across Iconic Global Consumer Brands Through Product, Retail, and Marketing Transformation Company Pre-Announces First Quarter 2025 Net Sales of $1.4 billion and Earnings Per Diluted Share of $0.49, Meeting the High End of Sales Guidance and Exceeding EPS Guidance; Maintains 2025 Full-Year Outlook COLUMBUS, Ohio, May 19, 2025 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) today announced that the Company’s independent directors voted unanimously to appoint Daniel Heaf as Chief Executive Officer, effective immediately. Heaf will be appointed as a member of the Board immediately following the conclusion of the Company’s 2025 Annual Meeting of Shareholders. Heaf is a transformative leader with a deep consumer-centric mindset and a track record of driving bold innovation...

Continue reading

Duke Robotics Strengthens Global Growth Strategy with Appointment of Yuval Hogeg as International Business Development Director

Former Head of International Cooperation Unit at Israeli Prime Minister’s Office to Lead Duke Robotics’ Expansion into Key Global Markets FT. LAUDERDALE, FL, May 19, 2025 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB:DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics technology and autonomous drone solutions, today announced the appointment of Mr. Yuval Hogeg as the International Business Development Director of the Company. Mr. Hogeg brings over two decades of expertise in managing complex intelligence operations and cultivating high-level international partnerships. He has established an extensive diplomatic and business network spanning North America, the European Union, Gulf Cooperation Council nations, and strategic regions across Africa. Mr. Hogeg’s appointment supports and strengthens Duke...

Continue reading

Form 8.3 – H&T Group plc – GB00B12RQD06 – Octopus Invesments

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Full name of discloser: OCTOPUS INVESTMENTS LTD(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree H&T Group plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)        Date position held/dealing undertaken:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.